Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation. | Int J Mol Sci | 2022 | 36555243 | PubTator, text mining | PubMed |
| Teratoid Hepatoblastoma-Our Experience. | Cancers (Basel) | 2022 | 36551621 | PubTator, text mining | PubMed |
| Single-cell transcriptomic, transcriptomic, and metabolomic characterization of human atherosclerosis. | Ann Transl Med | 2022 | 36544681 | PubTator, text mining | PubMed |
| Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis. | Med Oncol | 2022 | 36538194 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Coagulation- and fibrinolysis-related genes for predicting survival and immunotherapy efficacy in colorectal cancer. | Front Immunol | 2022 | 36532065 | PubTator, text mining | PubMed |
Plasma proteomics reveals early, broad release of chemokine, cytokine, TNF, and interferon mediators following trauma with delayed increases in a subset of chemokines and cytokines in patients that remain critically ill. | Front Immunol | 2022 | 36532045 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer. | World J Surg Oncol | 2022 | 36517818 | PubTator, text mining | PubMed |
| Coarse-grained modelling to predict the packing of porous organic cages. | Chem Sci | 2022 | 36507173 | PubTator, text mining | PubMed |
| Buckling Behavior of Sandwich Cylindrical Shells Covered by Functionally Graded Coatings with Clamped Boundary Conditions under Hydrostatic Pressure. | Materials (Basel) | 2022 | 36500176 | PubTator, text mining | PubMed |
| Detection of SARS-CoV-2 Virus by Triplex Enhanced Nucleic Acid Detection Assay (TENADA). | Int J Mol Sci | 2022 | 36499587 | PubTator, text mining | PubMed |
| The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations. | Cells | 2022 | 36497078 | PubTator, text mining | PubMed |
| CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma. | J Int Med Res | 2022 | 36495170 | PubTator, text mining | PubMed |
| Similarities between maternal and fetal RR interval tachograms and their association with fetal development. | Front Physiol | 2022 | 36479345 | PubTator, text mining | PubMed |
| Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 36470669 | PubTator, text mining | PubMed |
| Multiclonal human origin and global expansion of an endemic bacterial pathogen of livestock. | Proc Natl Acad Sci U S A | 2022 | 36469788 | PubTator, text mining | PubMed |
| Prognostic value of PNN in prostate cancer and its correlation with therapeutic significance. | Front Genet | 2022 | 36468018 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis. | Ann Transl Med | 2022 | 36467341 | PubTator, text mining | PubMed |
| ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer. | Biomed Res Int | 2022 | 36457341 | PubTator, text mining | PubMed |
| Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. | NPJ Precis Oncol | 2022 | 36456685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=30